Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor A Levin

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Cancer Chemotherapy and Pharmacology|March 29, 2011
An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology settingAthanassios P Kyritsis, Victor A Levin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2014
Getting more out of survival data by using the hazard functionKenneth R Hess, Victor A Levin
Cancer Management and Research|December 29, 2010
Role of bevacizumab therapy in the management of glioblastomaScott J Peak, Victor A Levin
Technology in Cancer Research & Treatment|July 23, 2008
A new preclinical 3-dimensional agarose colony formation assayYoshinori Kajiwara, Sonali Panchabhai, Victor A Levin
BMC Cancer|June 26, 2007
Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomasVictor A Levin, Sandra Ictech, Kenneth R Hess
Cancer Chemotherapy and Pharmacology|November 2, 2011
A systematic approach to the management of patients with brain metastases of known or unknown primary siteAthanassios P Kyritsis, Sofia Markoula, Victor A Levin
Nutrition and Cancer|February 9, 2011
Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agentsAthanassios P Kyritsis, Melissa L Bondy, Victor A Levin
Journal of Neuro-Oncology|August 22, 2007
Chemotherapy as first line treatment for oligodendrogliomaAthanassios P Kyritsis, Vinay K Puduvalli, Victor A Levin
CNS Oncology|January 31, 2018
Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomasVictor A Levin, Sandra E Ictech, Kenneth R Hess
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 22, 2022
Radiographic Response Assessment Strategies for Early-Phase Brain Trials in Complex Tumor Types and Drug Combinations: from Digital "Flipbooks" to Control Systems TheoryBenjamin M Ellingson, Victor A Levin, Timothy F Cloughesy
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|March 29, 2011
An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology settingAthanassios P Kyritsis, Victor A Levin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2014
Getting more out of survival data by using the hazard functionKenneth R Hess, Victor A Levin
Cancer Management and Research|December 29, 2010
Role of bevacizumab therapy in the management of glioblastomaScott J Peak, Victor A Levin
Technology in Cancer Research & Treatment|July 23, 2008
A new preclinical 3-dimensional agarose colony formation assayYoshinori Kajiwara, Sonali Panchabhai, Victor A Levin
BMC Cancer|June 26, 2007
Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomasVictor A Levin, Sandra Ictech, Kenneth R Hess
Cancer Chemotherapy and Pharmacology|November 2, 2011
A systematic approach to the management of patients with brain metastases of known or unknown primary siteAthanassios P Kyritsis, Sofia Markoula, Victor A Levin
Nutrition and Cancer|February 9, 2011
Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agentsAthanassios P Kyritsis, Melissa L Bondy, Victor A Levin
Journal of Neuro-Oncology|August 22, 2007
Chemotherapy as first line treatment for oligodendrogliomaAthanassios P Kyritsis, Vinay K Puduvalli, Victor A Levin
CNS Oncology|January 31, 2018
Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomasVictor A Levin, Sandra E Ictech, Kenneth R Hess
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 22, 2022
Radiographic Response Assessment Strategies for Early-Phase Brain Trials in Complex Tumor Types and Drug Combinations: from Digital "Flipbooks" to Control Systems TheoryBenjamin M Ellingson, Victor A Levin, Timothy F Cloughesy
Pageof 6